Free Trial

Annexon (ANNX) Competitors

Annexon logo
$4.20 +0.09 (+2.19%)
As of 01/17/2025 04:00 PM Eastern

ANNX vs. CNTA, MESO, IDYA, AGIO, APGE, AMPH, IOVA, TARS, IRON, and IBRX

Should you be buying Annexon stock or one of its competitors? The main competitors of Annexon include Centessa Pharmaceuticals (CNTA), Mesoblast (MESO), IDEAYA Biosciences (IDYA), Agios Pharmaceuticals (AGIO), Apogee Therapeutics (APGE), Amphastar Pharmaceuticals (AMPH), Iovance Biotherapeutics (IOVA), Tarsus Pharmaceuticals (TARS), Disc Medicine (IRON), and ImmunityBio (IBRX). These companies are all part of the "pharmaceutical products" industry.

Annexon vs.

Annexon (NASDAQ:ANNX) and Centessa Pharmaceuticals (NASDAQ:CNTA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Annexon has higher earnings, but lower revenue than Centessa Pharmaceuticals. Centessa Pharmaceuticals is trading at a lower price-to-earnings ratio than Annexon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AnnexonN/AN/A-$134.24M-$1.05-4.00
Centessa Pharmaceuticals$6.85M291.80-$151.09M-$1.53-9.91

82.0% of Centessa Pharmaceuticals shares are owned by institutional investors. 12.7% of Annexon shares are owned by company insiders. Comparatively, 11.6% of Centessa Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Annexon presently has a consensus target price of $15.80, suggesting a potential upside of 276.19%. Centessa Pharmaceuticals has a consensus target price of $25.83, suggesting a potential upside of 70.40%. Given Annexon's higher probable upside, equities research analysts plainly believe Annexon is more favorable than Centessa Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Annexon
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Centessa Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

Annexon's return on equity of -38.99% beat Centessa Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
AnnexonN/A -38.99% -33.90%
Centessa Pharmaceuticals N/A -52.13%-38.01%

In the previous week, Annexon had 5 more articles in the media than Centessa Pharmaceuticals. MarketBeat recorded 8 mentions for Annexon and 3 mentions for Centessa Pharmaceuticals. Annexon's average media sentiment score of 0.78 beat Centessa Pharmaceuticals' score of 0.71 indicating that Annexon is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Annexon
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Centessa Pharmaceuticals
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Annexon received 24 more outperform votes than Centessa Pharmaceuticals when rated by MarketBeat users. Likewise, 77.14% of users gave Annexon an outperform vote while only 57.69% of users gave Centessa Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
AnnexonOutperform Votes
54
77.14%
Underperform Votes
16
22.86%
Centessa PharmaceuticalsOutperform Votes
30
57.69%
Underperform Votes
22
42.31%

Annexon has a beta of 1.11, suggesting that its share price is 11% more volatile than the S&P 500. Comparatively, Centessa Pharmaceuticals has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500.

Summary

Annexon beats Centessa Pharmaceuticals on 11 of the 15 factors compared between the two stocks.

Get Annexon News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ANNX vs. The Competition

MetricAnnexonPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$447.70M$6.58B$5.35B$9.06B
Dividend YieldN/A2.94%5.13%4.02%
P/E Ratio-4.009.8389.4817.34
Price / SalesN/A307.731,251.60134.53
Price / CashN/A61.4443.7535.97
Price / Book1.316.055.324.80
Net Income-$134.24M$154.62M$122.60M$224.91M
7 Day Performance-13.04%-1.70%0.88%1.90%
1 Month Performance-15.15%2.75%4.81%5.08%
1 Year Performance-3.00%2.60%27.90%21.15%

Annexon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ANNX
Annexon
2.2971 of 5 stars
$4.20
+2.2%
$15.80
+276.2%
-8.7%$447.70MN/A-4.0060Short Interest ↑
CNTA
Centessa Pharmaceuticals
2.7184 of 5 stars
$15.09
-3.5%
$25.83
+71.2%
+90.5%$1.99B$6.85M-9.86200
MESO
Mesoblast
0.8007 of 5 stars
$17.18
-4.0%
$13.50
-21.4%
+894.3%$1.97B$5.90M0.0080Short Interest ↑
Gap Down
IDYA
IDEAYA Biosciences
3.9805 of 5 stars
$22.69
-5.6%
$53.67
+136.5%
-45.7%$1.96B$3.92M-9.7480Analyst Forecast
Short Interest ↑
AGIO
Agios Pharmaceuticals
3.81 of 5 stars
$34.04
-1.1%
$56.33
+65.5%
+49.3%$1.94B$32.87M3.00390Short Interest ↑
APGE
Apogee Therapeutics
2.5317 of 5 stars
$40.41
-1.6%
$89.71
+122.0%
+17.3%$1.82BN/A-16.7091
AMPH
Amphastar Pharmaceuticals
4.5112 of 5 stars
$37.53
+3.2%
$60.33
+60.8%
-36.4%$1.80B$723.55M12.511,620Short Interest ↑
IOVA
Iovance Biotherapeutics
4.1591 of 5 stars
$5.84
-8.8%
$23.00
+293.8%
-26.5%$1.78B$90.86M-3.92500News Coverage
Gap Up
TARS
Tarsus Pharmaceuticals
1.812 of 5 stars
$46.34
-12.1%
$54.20
+17.0%
+98.6%$1.77B$129.62M-12.1650News Coverage
Positive News
Gap Down
IRON
Disc Medicine
2.5686 of 5 stars
$58.39
-1.5%
$87.50
+49.9%
-10.4%$1.74BN/A-14.6730Short Interest ↑
News Coverage
IBRX
ImmunityBio
2.3566 of 5 stars
$2.48
+2.5%
$13.58
+447.7%
-19.5%$1.73B$7.33M-2.70590Analyst Forecast
Options Volume
News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:ANNX) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners